$Avalo Therapeutics(AVTX.US)$ From June to now, half a year has fallen to this point. Has the company reviewed the reason? Have any improvements been proposed?

$Avalo Therapeutics(AVTX.US)$ If the result of RS is that shareholders lose more and more, then what is the point of this kind of survival?

$Avalo Therapeutics(AVTX.US)$ Is there any hope for this company? Has there been any improvement in management methods? Are there any profit measures? Will RS continue to plummet by more than 50%?

$Avalo Therapeutics(AVTX.US)$ When is the reverse split?

$Avalo Therapeutics(AVTX.US)$
On November 14, 2023, the Company received written notice from Nasdaq (the “November Notification Letter”) that the Panel had granted the Company an exception from compliance with the MVLS Rule and the Bid Price Rule and extension of continued listing until December 29, 2023, subject to the following:
1.On or before November 9, 2023, the Company will demonstrate compliance with Listing Rule 5550(b)(1) by filing its Form 10-Q with the SEC evidencing a ...

$Avalo Therapeutics(AVTX.US)$ Hey, it's possible to split in reverse, ?$#@$

$Avalo Therapeutics(AVTX.US)$ I have to wait for the 30th to drop the line

$Avalo Therapeutics(AVTX.US)$ You can enter the market if you don't reach a new low

$Avalo Therapeutics(AVTX.US)$ Stayed at 0.1250, bright next week

$Avalo Therapeutics(AVTX.US)$ Looking at the close without breaking 0.1250, next week will be bright